Zydus Cadila Seeks DCGI Nod for Human Clinical Trials of Antibodies Cocktail to Treat Covid-19 in Top Business News- News18.com published on May 27, 2021 leave a reply Zydus said it is the only Indian company to have developed a neutralizing monoclonal antibody based cocktail for the treatment of COVID-19. from Top Business News- News18.com https://ift.tt/3yB06DT Tweet Share Share Share Share Previous Post Bitcoin: Indian Investors Can Lend Cryptocurrencies and Earn More Returns. How It Works Next Post Punjab Education Recruitment 2021 for 90 Teacher Posts, Apply Online @educationrecruitmentboard.com post written by: Rohit Related PostsBrain Drain 2.0: India’s Bitcoin Pool is Drying Up, Thanks to Govt’s Financial PoliciesThe migration has been triggered by various moves of the central government to ring-fence all things cryptocurrency in the country. from Top Business News- New… Continue ReadingMarket Rout Wipes out Rs 3.62 Lakh Crores from Investor Wealth in 3 DaysMarket analysts said that trade war escalation issues between US and China, increasing crude oil prices and depreciating rupee against the dollar have dampened … Continue ReadingSensex Ends With Losses, Fails to Keep Early LeadStocks saw a positive start as the Sensex touched a high of 37,530.63 intra-day in tune with the rupee recovering from its record low. from Top Business News- … Continue ReadingIGL to Set Up 60 CNG Stations, Give 2 Lakh Connections in FY19Indraprastha Gas Limited with 452 CNG stations in Delhi, Noida, Greater Noida, Ghaziabad and Rewari, has started to give the franchise to dealers who own lands.… Continue ReadingAmazon, Samara Buy India's 'More' Retail Chain for Rs 4,200 CroreAmazon's latest acquisition adds more heat to the US e-commerce giant's battle with Walmart Inc in the Indian market, after Walmart acquired Indian firm Flipkar… Continue Reading
0 comments: